Ultrasound contrast using halogenated xanthenes

Details Ultrasound contrast using halogenated xanthenes Ultrasound contrast using halogenated xanthenes

2006-01-17

2006-01-17

Smith, Ruth S. (Department: 3737)

Surgery

Diagnostic testing

Detecting nuclear, electromagnetic, or ultrasonic radiation

C424S009500

Reexamination Certificate

active

06986740

ABSTRACT:
New contrast agents for ultrasound imaging and methods for use of such agents for imaging of human or animal tissue are described, wherein a primary active component of such medicaments is a halogenated xanthene or halogenated xanthene derivative. Preferably, the halogenated xanthene is Rose Bengal or a functional derivative of Rose Bengal.

REFERENCES:
patent: 3868950 (1975-03-01), Kato
patent: 3986513 (1976-10-01), Stuhl
patent: 4172979 (1979-10-01), Morrison
patent: 4444189 (1984-04-01), Seiverd
patent: 4599227 (1986-07-01), Dees et al.
patent: 4691332 (1987-09-01), Burstein et al.
patent: 4856528 (1989-08-01), Yang et al.
patent: 4973848 (1990-11-01), Kolobanov et al.
patent: 5008907 (1991-04-01), Norman et al.
patent: 5053006 (1991-10-01), Watson
patent: 5128139 (1992-07-01), Brown et al.
patent: 5149801 (1992-09-01), Kahl et al.
patent: 5258453 (1993-11-01), Kopecek et al.
patent: 5284831 (1994-02-01), Kahl et al.
patent: 5368031 (1994-11-01), Cline et al.
patent: 5445608 (1995-08-01), Chen et al.
patent: 5456901 (1995-10-01), Unger
patent: 5462053 (1995-10-01), Briggs et al.
patent: 5576013 (1996-11-01), Williams et al.
patent: 5579773 (1996-12-01), Vo-Dinh et al.
patent: 5591422 (1997-01-01), Hemmi et al.
patent: 5622946 (1997-04-01), Sessler et al.
patent: 5632970 (1997-05-01), Sessler et al.
patent: 5645816 (1997-07-01), Unger
patent: 5654423 (1997-08-01), Kahl et al.
patent: 5702683 (1997-12-01), Smith et al.
patent: 5706810 (1998-01-01), Rubinsky et al.
patent: 5827186 (1998-10-01), Chen et al.
patent: 5829448 (1998-11-01), Fisher et al.
patent: 5832931 (1998-11-01), Wachter et al.
patent: 5876697 (1999-03-01), Soetanto
patent: 5998597 (1999-12-01), Fisher et al.
patent: 6036941 (2000-03-01), Bottiroli et al.
patent: 6042603 (2000-03-01), Fisher et al.
patent: 6063400 (2000-05-01), Geho et al.
patent: 6331286 (2001-12-01), Dees et al.
patent: 6493570 (2002-12-01), Dees et al.
patent: 2001/0041163 (2001-11-01), Sugita et al.
patent: 4403789 (1995-08-01), None
patent: WO98/01131 (1998-01-01), None
patent: WO 98/48845 (1998-11-01), None
patent: WO 99/30620 (1999-06-01), None
patent: WO 00/25665 (2000-05-01), None
patent: WO 00/25819 (2000-05-01), None
patent: WO 00/25829 (2000-05-01), None
patent: WO 02/060524 (2002-08-01), None
Fisher, A. et al, “Clinical and Preclinical Photodynamic Therapy,” Lasers in Surgery and Medicine, vol. 17, pp. 2-31 (1995).
Delprat, G.D. et al, “A New Liver Function Test, The Elimination of Rose Bengal when Injected into the Circulation of Human Subjects,” Arch Intern Med, vol. 34, pp. 533-541 (1924).
Wilson, F.M., et al, “Rose Bengal Staining of Epibulbar Squamous Neoplasms,” Ophthalmic Surgery, vol. 7 , No. 2, pp. 21-23 (1976).
Merck Index, 12thEd., entry 5055, 5068, 5069, 5071 (1996).
RTEC entry No. WN2817000 (N-Iodosuccinimide) and PB7000000 (Iodoform).
Young, S. et al, “Gadolinium (III) Texaphyrin: A Tumor Selective Radiation Sensitizer that is Detectable by MRI,” Proc. Natl. Acad. Sci., vol. 93, pp. 6610-6615 (1996).
Bernhard, E.J. et al, “Re-Evaluating Gadolinium (III) Texaphyrin as a Radiosensitizing Agent,” Cancer Research, vol. 60, pp. 86-91, (2000).
Huang, A.J.W. et al, “Photothrombosis of Corneal Neovascularization by Intravenous Rose Bengal and Argon Laser Irradiation,” Arch Ophthalmol vol. 106, pp. 680-685, (1988).
Neckers, D.C., “Rose Bengal,” Journal of Photochemistry and Photobiology, A: Chemistry, vol. 47, pp. 1-29 (1989).
Lindman, B. et al,Chlorine, Bromine and Iodine NMR, Physico-Chemical and Biological Applications, Springer-Verlag, Berlin, Germany (1976).
Engelstad, B.L. et al, “Contrast Agents,”Magnetic Resonance Imaging, Chapter 9, pp. 161-181, C.V. Mosby Company, St. Louis, MO (1988).
Lauffer, R.B. et al, Chapter 5: “MRI Contrast Agents: Basic Principles,” and Chapter 6: “Organ and Tissue Directed MRI Contrast Agents,”MRI Clinical Magnetic Resonance Imaging, 2ndedition, W.B. Sanders Company, Philadelphia, PA, pp. 177-213 (1996).
Streitwieser, Jr. et al, Chapter 22: “Benzene and the Aromatic Ring,”Introduction to Organic Chemistry, 2ndedition, Macmillan Publishing Company, NY, pp. 652-656 (1981).
Bezman, S.A. et al, “Photodynamic Inactivation ofE. Coliby Rose Bengal Immobilized on Polystyrene Beads,” Photochemistry and Photobiology, vol. 28, pp. 325-329 (1978).
Fluhler, E.N. et al, “Laser Intensity and Wavelength Dependence of Rose-Bengal-Photosensitized Inhibition of Red Blood Cell Acetylcholinesterase,” Biochimica et Biophysica Acta, vol. 990, pp. 269-275 (1989).
Kremkau, F.W., Chapter 2: “Ultrasound,”Diagnostic Ultrasound, Principles, Instrumentation and Exercises, 2ndedition, Grune & Stratton, Inc., Orlando, Florida, pp. 5-35 (1984).
PCT International Search Report dated May 7, 2004 with regard corresponding PCT application PCT/US 03/39044.

Affiliated with

Also associated with

Rating

Ultrasound contrast using halogenated xanthenes does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Ultrasound contrast using halogenated xanthenes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Ultrasound contrast using halogenated xanthenes will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3568129